One thing which I always want to see is how does our drug or technology compare to the similar or upcoming competition and companies.
Unfortunately seems Cynata is the first one to have a human trial and no results out there to compare... is my understanding correct?
I mean the tech and opportunities seems very exciting.. having published in nature medicine is great ...
But I am sure it is not a 6-12 months game of big returns... patience is required ... and a lot ..... but happy to play the patience game... mostly pays off in biotech ...now hope my order on Monday gets filled
Cynata in 10, page-41
-
- There are more pages in this discussion • 160 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
27.0¢ |
Change
-0.005(1.82%) |
Mkt cap ! $48.78M | |||
| Open | High | Low | Value | Volume |
| 27.5¢ | 28.5¢ | 26.5¢ | $71.17K | 257.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 145786 | 27.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.0¢ | 15000 | 1 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| CYP (ASX) Chart |